Northern Trust’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-203,833
| Closed | -$336K | – | 4861 |
|
2022
Q1 | $336K | Sell |
203,833
-12,931
| -6% | -$21.3K | ﹤0.01% | 3897 |
|
2021
Q4 | $519K | Sell |
216,764
-5,496
| -2% | -$13.2K | ﹤0.01% | 3799 |
|
2021
Q3 | $1.21M | Buy |
222,260
+12,684
| +6% | +$69.3K | ﹤0.01% | 3491 |
|
2021
Q2 | $1.56M | Buy |
209,576
+7,841
| +4% | +$58.4K | ﹤0.01% | 3424 |
|
2021
Q1 | $1.64M | Sell |
201,735
-510
| -0.3% | -$4.13K | ﹤0.01% | 3354 |
|
2020
Q4 | $1.84M | Buy |
202,245
+501
| +0.2% | +$4.56K | ﹤0.01% | 3230 |
|
2020
Q3 | $2.23M | Buy |
201,744
+10,713
| +6% | +$119K | ﹤0.01% | 3011 |
|
2020
Q2 | $1.42M | Buy |
191,031
+63,714
| +50% | +$474K | ﹤0.01% | 3214 |
|
2020
Q1 | $783K | Buy |
127,317
+4,613
| +4% | +$28.4K | ﹤0.01% | 3317 |
|
2019
Q4 | $616K | Buy |
122,704
+50,563
| +70% | +$254K | ﹤0.01% | 3515 |
|
2019
Q3 | $543K | Buy |
72,141
+59,656
| +478% | +$449K | ﹤0.01% | 3520 |
|
2019
Q2 | $145K | Buy |
+12,485
| New | +$145K | ﹤0.01% | 3888 |
|